Actively Recruiting

Age: 18Months +
All Genders
ID07596303

Exploratory Pilot Study of BÜHLMANN Automated Basophil Activation Test as an Aid to Diagnosis of Immediate Type Allergic Disorders

Led by Bühlmann Laboratories AG · Updated on 2026-06-01

60

Participants Needed

1

Research Sites

17 weeks

Total Duration

On this page

Sponsors

B

Bühlmann Laboratories AG

Lead Sponsor

T

Technical University Munchen

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this exploratory pilot study is to generate early data needed for future validation studies of the automated BÜHLMANN BAT (Basophil activation test) assay. The main questions it aims to answer are: Does the BAT assay use the optimal allergen concentrations for stimulation, and how do its preliminary cut-offs perform in a real-world clinical scenario? Participants older than 1.5 years who are being evaluated for possible allergy sensitization will provide one additional blood tube during their routine blood draw as part of the regular medical care. The study involves only one visit and does not provide direct personal benefit.

CONDITIONS

Brief Title

BÜHLMANN BAT (Basophil Activation Test) in Allergy Diagnosis (Exploratory Pilot Study)

Who Can Participate

Age: 18Months +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals with diagnosis of a hypersensitivity / allergy to one of the 6 allergens, established according to common clinical practice
Not Eligible

You will not qualify if you...

  • Pregnant women
  • Children under the age of 18 months
  • Individuals under therapy with Omalizumab or Rituximab
  • Individuals with an allergic reaction less than two weeks before blood sample collection
  • Individuals under therapy with BTK inhibitors
  • Individuals receiving allergen specific immunotherapy (ASIT)
  • Subjects with active infection and inflammatory conditions
  • Patients who are unable to understand the study information and informed consent form in German

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, TUM Universitätsklinikum rechts der Isar,

München, Germany

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Long Term Outcomes After Oral Immunotherapy for Peanut, Egg,...

Food Allergies

Actively Recruiting

1 location

Blood Samples for the Study of Peanut, Tree Nut and Other Fo...

Peanut Allergies

Actively Recruiting

1 location

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here